Outlook Therapeutics (OTLK) Earnings Date, Estimates & Call Transcripts → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free OTLK Stock Alerts $7.94 +0.03 (+0.38%) (As of 05/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueOTLK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OTLK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution Outlook Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.05)($0.04)($0.05)Q2 20243($1.28)($0.42)($0.88)Q3 20243($1.09)($0.64)($0.86)Q4 20243($0.89)($0.61)($0.71)FY 202412($3.31)($1.71)($2.50)Q1 20251($1.00)($1.00)($1.00)Q2 20251($0.50)($0.50)($0.50)Q3 20251($0.31)($0.31)($0.31)Q4 20251($0.31)($0.31)($0.31)FY 20254($2.12)($2.12)($2.12) Get Outlook Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for OTLK and its competitors with MarketBeat's FREE daily newsletter. OTLK Earnings Date and InformationOutlook Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.Read More Outlook Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/12/2024(Estimated)------- 2/14/2024Q1 2024($1.00)($0.80)+$0.20($0.04)--12/22/2023Q4 2023($1.00)($1.00)-($0.05)--8/14/2023Q3 2023($0.80)($1.60)($0.80)($0.08)--5/15/2023Q2 2023($1.20)($0.60)+$0.60($0.03)--2/14/2023Q1 2023($0.80)($1.60)($0.80)($0.08)--8/10/2022Q3 2022($1.60)($1.60)-($0.08)-- Get the Latest News and Ratings for OTLK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/13/2022Q2 2022($1.40)($1.80)($0.40)($0.09)-- 2/13/2022Q1 2022($1.20)($1.60)($0.40)($0.08)-- 12/22/2021Q3 2021($1.20)($1.80)($0.60)($0.08)--8/12/2021Q2 2021($1.40)($1.40)-($0.07)--5/14/2021Q1 2021($2.00)($1.80)+$0.20($0.09)--2/16/2021Q4 2020($1.60)($2.40)($0.80)($0.12)--12/22/2020Q3 2020($1.60)($2.60)($1.00)---8/14/2020Q3 2020($1.40)($0.60)+$0.80($0.03)--5/15/2020Q2 2020($2.00)($7.20)($5.20)($0.36)--2/14/2020Q1 2020-($5.80)($5.80)$0.04--12/19/2019Q4 2019($6.20)($2.40)+$3.80($0.24)$0.63 million$5.85 million8/14/2019Q3($7.40)($4.80)+$2.60($0.28)$0.73 million$0.58 million Outlook Therapeutics Earnings - Frequently Asked Questions When is Outlook Therapeutics's earnings date? Outlook Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on OTLK's earnings history. How much profit does Outlook Therapeutics generate each year? Outlook Therapeutics (NASDAQ:OTLK) has a recorded net income of -$58.98 million. OTLK has generated -$11.41 earnings per share over the last four quarters. What is Outlook Therapeutics's EPS forecast for next year? Outlook Therapeutics's earnings are expected to grow from ($4.02) per share to ($2.44) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Athira Pharma Earnings bluebird bio Earnings BioAtla Earnings AlloVir Earnings Precision BioSciences Earnings Gritstone bio Earnings Protalix BioTherapeutics Earnings Cognition Therapeutics Earnings Omega Therapeutics Earnings DBV Technologies Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: TD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's Earnings This page (NASDAQ:OTLK) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outlook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
